Cancer Market Research, Intelligence and Forescasts
In this section you will find information products, including market research, covering Cancer research, including latest technologies, company profiles, biopharmaceuticals, market data and information covering Europe, the UK, North America and Asia.
Stay up-to-date with new products added to this category »
|
Title
|
Publication Date
|
Price
|
|
Triple Analysis: Apoptosis, Angiogenesis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Melanoma and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Prostate Cancer, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Prostate Cancer and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Apoptosis and Angiogenesis
|
December 2011 |
£2865 |
|
Triple Analysis: Lung Cancer, Apoptosis and Peptides
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Prostate Cancer and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Melanoma, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Lung Cancer, Apoptosis and Cancer Vaccines
|
December 2011 |
£2865 |
|
Triple Analysis: Apoptosis, Angiogenesis and Protein Kinase Inhibitors
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Melanoma and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Pancreatic Cancer and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Apoptosis, Protein Kinase Inhibitors and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Apoptosis and Protein Kinase Inhibitors
|
December 2011 |
£2865 |
|
Triple Analysis: Lung Cancer, Apoptosis and Angiogenesis
|
December 2011 |
£2865 |
|
Triple Analysis: Pancreatic Cancer, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Apoptosis and Protein Kinase Inhibitors
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Apoptosis and Peptides
|
December 2011 |
£2865 |
|
Triple Analysis: Lung Cancer, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Apoptosis and Cancer Vaccines
|
December 2011 |
£2865 |
Commercializing Apoptotic Drugs in Cancer
The Faster Route to Consider Your Options and Position of Others
|
December 2011 |
£2035 |
|
Triple Analysis: Apoptosis, Angiogenesis and Cancer Vaccines
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Leukemia and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Leukemia, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Lung Cancer and Apoptosis
|
December 2011 |
£2865 |
|
Triple Analysis: Breast Cancer, Apoptosis and Antibodies
|
December 2011 |
£2865 |
|
Triple Analysis: Apoptosis, Angiogenesis and Peptides
|
December 2011 |
£2865 |
|
Triple Analysis: Colorectal Cancer, Pancreatic Cancer and Apoptosis
|
December 2011 |
£2865 |
